document.write("<table BORDER=0 CELLPADDING=0 CELLSPACING=0 width=200><tr><td><img SRC=http://cancernews.com/java/images/logos/java_top.gif WIDTH=200 HEIGHT=57></td></tr><tr><td background=http://cancernews.com/java/images/logos/java_mid_back.gif ALIGN=CENTER><table BORDER=0 WIDTH=85%><tr><td><font FACE=VERDANA COLOR=NAVY SIZE=0><table border=0 cellpadding=0 cellspacing=0 width=100%><tr><td><br><b><font face=verdana color=navy size=2>Velcade: A New Strategy Treating Multiple Myeloma</font></b>&nbsp;<br><font face=verdana color=navy size=1>                        <center>Velcade: A New Strategy for Treating Multiple Myeloma<br><br>       </font><a href=http://cancernews.com/data/Article/278.asp target=new><img border=0 src=http://cancernews.com/java/images/more.gif></a></td></tr></table><table border=0 cellpadding=0 cellspacing=0 width=100%><tr><td><br><b><font face=verdana color=navy size=2>New Multiple Myeloma Drug Proves More Potent than Thalidomide </font></b>&nbsp;<br><font face=verdana color=navy size=1>Source: Dana-Farber Cancer Institute September 19, 2006<br><br>New multiple myeloma drug proves </font><a href=http://cancernews.com/data/Article/352.asp target=new><img border=0 src=http://cancernews.com/java/images/more.gif></a></td></tr></table><table border=0 cellpadding=0 cellspacing=0 width=100%><tr><td><br><b><font face=verdana color=navy size=2>Multiple Myeloma: New Drug Shows Positive Responses, Low Side-Effects in Clinical Trial</font></b>&nbsp;<br><font face=verdana color=navy size=1>Source: M. D. Anderson News Release 12/07/09<br><br><center><font size=+1>Drug Shows Positive </font><a href=http://cancernews.com/data/Article/755.asp target=new><img border=0 src=http://cancernews.com/java/images/more.gif></a></td></tr></table></font><br><hr><center><a class=link target=_new href=http://www.ShoppingNews.com>Sponsored by :<br>ShoppingNews.com<br></a></center></td></tr></table></td></tr><tr><td><img SRC=http://cancernews.com/java/images/logos/java_bottom.gif WIDTH=200 HEIGHT=43></td></tr></table><br>")